Kite Pharma Details CAR-T Therapy Launch, Floats Pricing Benchmarks

Kite plans to initially target 72 clinical institutions experienced with CAR-T for its KTE-C19 launch, including 10 from the get-go.

More from Anticancer

More from Therapy Areas